Pizzie Nick

CIK 00017421431 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001742143

Recent Transactions

39 trades

Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2026-01-22−12,000→ 105,000 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-01-22$3.50/sh+12,000→ 54,588 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-01-22$187.92/sh−12,000→ 42,588 total
Award
Axsome Therapeutics, Inc.$AXSM
Performance Stock Units
2025-02-24+9,423→ 9,423 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2025-02-21+9,516→ 9,516 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2025-02-21+9,423→ 9,423 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-02-14$131.07/sh−3,000→ 42,187 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-02-14$3.50/sh+3,000→ 45,187 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-02-14$3.50/sh−3,000→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-02-13$129.86/sh−12,000→ 42,187 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-02-13$3.50/sh+12,000→ 54,187 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-02-13$3.50/sh−12,000→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2024-02-27+15,774→ 15,774 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2024-02-27+28,722→ 28,722 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2023-03-02+20,554→ 20,554 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2023-03-02+36,246→ 36,246 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2022-03-04+41,176→ 41,176 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2022-03-04+77,872→ 77,872 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-18$35.43/sh+141→ 201 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-18$35.20/sh+142→ 142 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-18$34.30/sh+145→ 145 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-18$35.50/sh+527→ 41,789 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2021-11-12+36,086→ 36,086 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2021-03-05+36,086→ 36,086 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2021-03-05+19,208→ 19,208 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2020-06-29$76.64/sh+777→ 41,217 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2020-03-17+48,237→ 48,237 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2020-03-17+14,767→ 14,767 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2020-03-17+18,645→ 18,645 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2020-03-17+60,880→ 60,880 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (right to buy)
2019-10-10+25,813→ 25,813 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-09-26$24.80/sh+2,180→ 40,440 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-06-11$20.80/sh+1,920→ 1,920 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-03-19$12.69/sh+60→ 60 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-03-19$12.58/sh+5,340→ 36,340 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (right to buy)
2019-03-19+75,102→ 75,102 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2018-06-19$3.05/sh+400→ 400 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2018-06-19$3.10/sh+30,600→ 31,000 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (right to buy)
2018-05-16+132,000→ 132,000 total

Companies

Axsome Therapeutics, Inc.
Chief Financial Officer
$AXSM

Recent Filings

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007

View on SEC.gov